Skip to main content

Day: April 5, 2023

Verisk Named One of UK’s Best Workplaces for Wellbeing™ by Great Place to Work®

Verisk Named One of UK’s Best Workplaces for Wellbeing™ by Great Place to Work® Great Place to Work Best Workplaces for Wellbeing BadgeLONDON, April 05, 2023 (GLOBE NEWSWIRE) — Leading global data analytics and technology provider Verisk (Nasdaq: VRSK) has been recognised as one of the UK’s Best Workplaces™ for Wellbeing by Great Place to Work®, the global authority on workplace culture. This honour is based entirely on what current employees say about their experience working at Verisk. Great Place to Work’s culture experts analysed thousands of employee surveys, assessing people’s holistic experiences of wellbeing at work to determine the UK’s Best Workplaces™ for Wellbeing list.  The surveys asked employees to comment on how their company supports their work-life balance, sense of fulfilment, job...

Continue reading

AC Immune to Host Key Opinion Leader Webinar on Early Diagnosis and Prevention of Alzheimer’s Disease

AC Immune to Host Key Opinion Leader Webinar on Early Diagnosis and Prevention of Alzheimer’s DiseaseWebinar to take place on Tuesday, April 18, 2023, at 10:30 AM EDT / 4:30 PM CESTLausanne, Switzerland, April 5, 2023 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, will host a key opinion leader (KOL) webinar on early diagnosis and prevention of Alzheimer’s disease on Tuesday, April 18, 2023 at 10:30 AM EDT / 4:30 PM CEST. Andrea Pfeifer, PhD, AC Immune’s Chief Executive Officer, will begin the webinar with an overview of the company’s strategic direction and expectations for the year before introducing the invited speakers: Kaj Blennow, MD, PhD, of University of Gothenburg and Sahlgrenska University Hospital, and Giovanni Frisoni, MD, of University...

Continue reading

Oculis to Participate at Upcoming Investor Conferences

ZUG, Switzerland and BOSTON, April 05, 2023 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, announces that members of management will be participating in the following April investor conferences:22nd Annual Needham Virtual Healthcare Conference, including a presentation on Thursday, April 20, 2023 in Track 2 from 8:45 to 9:25 AM ET 16th Annual Kempen Life Sciences Conference, Amsterdam, Netherlands. Management will participate in investor meetings on Tuesday, April 25th, 2023The presentation at the 22nd Annual Needham Virtual Healthcare Conference will be available via a live webcast from the Events & Presentations section of the Oculis website. An archived replay of the on-demand presentation will be available on...

Continue reading

Osisko Windfall Infill and Expansion Drilling Continues to Intersect High-Grade in Lynx

New Results Include 286 g/t Au Over 2.1 Metres and 204 g/t Au Over 2.0 Metres TORONTO, April 05, 2023 (GLOBE NEWSWIRE) — Osisko Mining Inc. (OSK:TSX. “Osisko” or the “Corporation”) is pleased to provide new analytical results from the ongoing drill program at its 100% owned Windfall gold project located in the Abitibi greenstone belt, Urban Township, Eeyou Istchee James Bay, Québec. The targeted feasibility study surface drilling campaign was completed at the end of September 2022. In the past 6 months, over 55,000 metres additional have been drilled by 9 underground rigs focused on expansion and infill work in the Lynx segment of the deposit. Significant new analytical results are presented below and include 81 intercepts from 45 drill holes and 3 wedges. The infill intercepts are all located inside the...

Continue reading

Freight Technologies Inc. (FRGT) Reports Highest Monthly Increase in New Clients Since Fr8App Platform Inception

HOUSTON, April 05, 2023 (GLOBE NEWSWIRE) — Freight Technologies, Inc. (Nasdaq: FRGT) (“Fr8Tech”), a technology company offering its custom-developed Fr8App, an industry-leading freight-matching platform that offers a B2B cloud-base solution for cross-border and domestic shipping within the USMCA region, reports a record increase in the number of new shipper clients added during the month of March 2023. Following a challenging first quarter of the year “We have onboarded new clients in a variety of sectors including automotive, beverage, motorcycles and consumer goods that we had been working on for some time,” said Harry Martin, Sales Director for Freight Technologies. “The new shipper clients represent a potential for significant recurring traffic on our platform and include leading first tier automotive clients, renowned...

Continue reading

TransCode Therapeutics Receives Notice of Award from National Institutes of Health (NIH) for Third Year of Grant to Support Clinical Evaluation of TTX-MC138

BOSTON, April 05, 2023 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics, today announced that it has been awarded the third year of a Fast-Track Small Business Innovation Research (SBIR) grant from the NIH to support the clinical evaluation of TTX-MC138, TransCode’s lead therapeutic candidate for the treatment of advanced solid tumors. The award totals nearly $871,000. “We are honored that the NIH recognizes and continues to support our mission to overcome the obstacles of RNA delivery in oncology,” said Michael Dudley, President and Chief Executive Officer of TransCode. “We believe our TTX platform offers tremendous potential across a range of indications. Specifically, this third-year tranche of the SBIR grant...

Continue reading

With 8.4% CAGR, Home Healthcare Market Size to Hit USD 505.81 billion by 2030

The global home healthcare market size was valued at USD 277.11 billion in 2022 and is expected to be worth USD 288.38 billion in 2023. The market is projected to be valued at USD 505.81 billion by 2030, registering a CAGR of 8.4% during the forecast period of 2023-2030. Pune, India, April 05, 2023 (GLOBE NEWSWIRE) — The global home healthcare market size was valued at USD 277.11 billion in 2022 and is expected to be worth USD 288.38 billion in 2023. The market is projected to be valued at USD 505.81 billion by 2030, registering a CAGR of 8.4% during the forecast period of 2023-2030. Home healthcare mainly consists of many healthcare services that are provided to patients at home. These services include providing intravenous & nutrition therapy, monitoring severe illnesses & injuries, respiratory therapy services, wound...

Continue reading

The Simply Good Foods Company Reports Second Quarter 2023 Financial Results and Updates Full Fiscal Year 2023 Outlook

DENVER, April 05, 2023 (GLOBE NEWSWIRE) — The Simply Good Foods Company (Nasdaq: SMPL) (“Simply Good Foods,” or the “Company”), a developer, marketer and seller of branded nutritional foods and snacking products, today reported financial results for the thirteen and twenty-six weeks ended February 25, 2023. Second Quarter Summary:(1)Net sales of $296.6 million versus $296.7 million Net income(2) of $25.6 million versus $18.5 million Earnings per diluted share (“EPS”)(2) of $0.25 versus $0.18 Adjusted Diluted EPS(3) of $0.32 versus $0.36 Adjusted EBITDA(4) of $50.9 million versus $54.2 millionFull Year Fiscal 2023 Outlook:Reaffirm full year net sales outlook that is expected to increase slightly greater than the Company’s long-term algorithm of 4-6%, including a headwind of almost 1 percentage point related to the frozen...

Continue reading

Goodfood to Report Second Quarter of Fiscal Year 2023 Results

MONTREAL, April 05, 2023 (GLOBE NEWSWIRE) — Goodfood Market Corp. (“Goodfood” or “the Company”) (TSX: FOOD), a leading Canadian online meal solutions company, will release its financial results for the second quarter of Fiscal 2023 on Wednesday, April 12, 2023, before markets open. Jonathan Ferrari, CEO, Neil Cuggy, President and COO, and Roslane Aouameur, CFO, will hold a conference call to review the results at 8:00 a.m. (ET) on the same day. Details of the Q2 Earnings Conference Call: When: April 12, 2023, at 8:00 a.m. ET Dial in number: 1 (888) 396-8049 or 1 (416) 764-8646 Conference call replay available until April 19, 2023:1 (877) 674-7070 or 1 (416) 764-8692Replay passcode: 463513# To access the webcast and view the slide presentation, click on this link:https://www.makegoodfood.ca/en/investisseurs/evenements The conference...

Continue reading

Probe Gold Appoints Renaud Adams to its Board of Directors

TORONTO, April 05, 2023 (GLOBE NEWSWIRE) — Probe Gold Inc. (TSX: PRB) (OTCQB: PROBF) (“Probe” or the “Company”) is very pleased to announce the appointment of Mr. Renaud Adams to its board of directors, effective immediately. Renaud Adams has over 30 years of global mining experience in senior executive positions and operations. Currently, Mr. Adams serves as the President and Chief Executive Officer of Iamgold Corporation. Previously, from 2018 to 2022, he was the President and Chief Executive Officer of New Gold Inc., where he led the strategic repositioning of the company and turnaround of its operations. Prior to New Gold, Mr. Adams was President and Chief Executive Officer of Richmont Mines Inc. from 2014 until the company was sold to Alamos Gold in November 2017. During Mr. Adams’ time at Richmont Mines, the primary...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.